Huge Decline in Medicare Laboratory Testing Due to COVID-19
According to a recent OIG report, fewer Medicare Part B beneficiaries received lab tests during the first 10 months of the pandemic.
According to a recent OIG report, fewer Medicare Part B beneficiaries received lab tests during the first 10 months of the pandemic.
Circulating tumor DNA sequencing technologies are tackling the challenges of early cancer detection.
Advances in MALDI time-of-flight mass spectrometry have significantly expanded its use in high-throughput diagnostic labs.
Researchers have identified 35 genes found in high expression in people with long-term Lyme disease, which could lead to earlier detection.
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.
Here’s a look at what labs need to know about the new rules that take effect on Jan. 1 as part of the 2023 Medicare Physician Fee Schedule.
CMS has instructed state surveyors to crack down on hospitals that don’t implement adequate workplace violence protections.
Labs will be able to bill Medicare and Medicaid for these new CLIA-waived tests, starting on April 1, 2023.
What labs need to know to maximize travel allowance reimbursements.
Labs will be able to bill their MACs for the newly recognized tests starting April 1, 2023.